DOI: 10.1055/s-00000125

Senologie - Zeitschrift für Mammadiagnostik und -therapie

References

Thill M, Schmidt M.
Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer.

Ther Adv Med Oncol 2018;
10: 1758835918793326 . doi:10.1177/1758835918793326

Download Bibliographical Data

Search in: